Literature DB >> 7300287

Construct validity of direct magnitude estimation and interval scaling of speech intelligibility: evidence from a study of the hearing impaired.

N Schiavetti, D E Metz, R W Sitler.   

Abstract

The appropriateness of direct magnitude estimation and interval scaling procedures for assessing the speech intelligibility of hearing-impaired adults was investigated by determining whether the continuum of the talkers' intelligibility was prothetic or metathetic. The intelligibility of 20 hearing-impaired talkers was scaled by 20 listeners using direct magnitude estimation and by 20 listeners using interval scaling. The two sets of scaling data were related in the curvilinear fashion that is typical of prothetic continua, indicating better construct validity for direct magnitude estimation than for interval scaling of speech intelligibility.

Entities:  

Mesh:

Year:  1981        PMID: 7300287     DOI: 10.1044/jshr.2403.441

Source DB:  PubMed          Journal:  J Speech Hear Res        ISSN: 0022-4685


  4 in total

1.  Speech treatment improves dysarthria in multisystemic ataxia: a rater-blinded, controlled pilot-study in ARSACS.

Authors:  Adam P Vogel; Lisa H Stoll; Andreas Oettinger; Natalie Rommel; Eva-Maria Kraus; Dagmar Timmann; Dion Scott; Christina Atay; Elsdon Storey; Ludger Schöls; Matthis Synofzik
Journal:  J Neurol       Date:  2019-03-06       Impact factor: 4.849

2.  Assessing Vowel Centralization in Dysarthria: A Comparison of Methods.

Authors:  Annalise R Fletcher; Megan J McAuliffe; Kaitlin L Lansford; Julie M Liss
Journal:  J Speech Lang Hear Res       Date:  2017-02-01       Impact factor: 2.297

3.  Assessing speech intelligibility in children with hearing loss: toward revitalizing a valuable clinical tool.

Authors:  David J Ertmer
Journal:  Lang Speech Hear Serv Sch       Date:  2010-07-02       Impact factor: 2.983

4.  Informativeness ratings of messages created on an AAC processing prosthesis.

Authors:  Megan R Bartlett; Ruth B Fink; Myrna F Schwartz; Marcia Linebarger
Journal:  Aphasiology       Date:  2007       Impact factor: 2.773

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.